RxDoctor Payments Data

Bernard Cohen

Pediatric Dermatology · Lutherville, MDNPI 1962454876

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $7,475 of the $12,389 with a category attached, or 60.3%. AbbVie accounts for 62.3% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2021 at $7,492 and has fallen 90.1% since, to $739 in 2025.

$12,389in general payments, 2019–2025

Across 28 payments — averaging $442.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$8K
  • Pfizer$2K
  • Nobelpharma America, LLC$726
  • Lilly USA, LLC$332
  • Galderma Laboratories, L.p.$300
  • Regeneron Healthcare Solutions, Inc.$264
  • plus $602 from 6 others
$332,850in research payments, 2019–2025

Across 2 payments — averaging $166,425 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$333K

What the payments were for

  • Consulting fees$7,47560%
  • Speaking & faculty fees$2,20018%
  • Travel & lodging$6325%
  • Food & beverage$2,08217%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric dermatology providers in Marylandto place this figure against a meaningful peer group, so we don't.

Other pediatric dermatology in Lutherville

Where these figures come from

Is this you, or does something look wrong? →